"Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Dementia With Lewy Bodies
Interventions
DRUG

Armodafinil

150-250 mg armodafinil by mouth daily

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Cephalon

INDUSTRY

collaborator

National Institute on Aging (NIA)

NIH

lead

Mayo Clinic

OTHER